Drug/drug group | Agreement on clinical significance | Most common actions taken | Other comments |
---|---|---|---|
PPI | Yes | Reduce dose | While it is clinically significant, it is also a cost control concern |
Stop medication | |||
Corticosteroids | Yes | Add medication | Â |
Long-term, long-acting benzodiazepines | Yes | Switch to alternative | Patient preference is an important factor. Availability of other services such as cognitive behavioural therapy is an important factor |
Reduce dose | |||
NSAID | Yes | Stop medication | Â |
Switch to alternative | |||
Bladder antimuscarinics | No | Leave unaltered | Patient preference is an important factor. Lack of good alternative options available |
Switch to alternative | |||
Tricyclic anti-depressants | No | Leave unaltered | Patient preference is an important factor |
Switch to alternative | |||
Reduce dose | |||
Therapeutic duplications | Yes | Stop medication | Â |
Switch to alternative | |||
Calcium channel blocker | No | Switch to alternative | Â |
Theophylline | Yes | Stop medication |